Sundar PichaiSundar Pichai earned $164M in 2023

Dan Greenleaf is currently the CEO of Option Care Health, Inc., a company focused on healthcare solutions. Born in 1965, he brings over two decades of experience in the healthcare industry. Before joining Option Care, Greenleaf served as the CEO...

Quick Links
O

Dan Greenleaf

Ex-CEO of Option Care Health, Inc.

Education

Not specified

Field of Expertise

Healthcare & Life Sciences - Healthcare

Sector of Economy

Healthcare

Born

June 1, 1965 - 60 years ago

CEO of Option Care Health, Inc. for

2 years 10 months (Sep 2016 - Aug 2019)

Previous Experience

Chairman and Chief Executive Officer of Home Solutions; President and Chief Executive Officer of Coram Specialty Infusion Services

Rivals

Competitors/colleagues of Dan Greenleaf

Holdings

See how much did Dan Greenleaf make over time.

Dan Greenleaf holds significant equity in Option Care Health, Inc. His holdings included 295,207 stock options and over 377,358 restricted stock units (RSUs) as of recent reports. These stock options give him the right to purchase shares at $1.11, set...

Loading...

Insider Trading

See recent insider trades of Dan Greenleaf.

No insider trades found for this CEO.

Compensation History

See how much did Dan Greenleaf make over time.

In 2019, Dan Greenleaf's total compensation was about $1,821,698. His base salary was $750,000, reflecting his role in leading Option Care Health. He also earned a performance-based bonus of approximately $313,562, factoring in his achievements aligned with the company’s goals. An interesting point is that this bonus was tied to specific objectives set ahead of his merger with Home Solutions. While in 2018 he received a total compensation of $1,511,989, his stock awards included $763,470 worth of RSUs that vested that year. Greenleaf’s compensation strategy is designed to tie his earnings closely to company performance, which is meant to motivate him and other executives to focus on long-term results and shareholder value.

Year

2019

Total Compensation

$1.82M

Salary

$750.00K

Board Justification

The compensation philosophy is to align executive compensation with the interests of stockholders, focusing on performance-based incentives to retain talented executives and drive company growth.

Bonus

$313.56K

Board Justification

Annual bonus based on the achievement of individual and corporate objectives established by BioScrip prior to the Merger, prorated for the period of service before the Merger.

Other

$759.14K

Board Justification

Includes accrued severance payments and other benefits.

Restricted Stock

$0.00(0 N/A)

Board Justification

No stock awards vested in 2019 as per the provided data.

Performance Metrics

Performance metrics included individual and corporate objectives established by BioScrip and adjusted EBITDA for the fourth quarter of 2019.